Bionik Laboratories (Bionik Laboratories) EV-to-EBIT : -0.67 (As of May. 05, 2024)

Bionik Laboratories EV-to-EBIT Chart

Bionik Laboratories Annual Data
	Trend	Dec14	Dec15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23
EV-to-EBIT		Get a 7-Day Free Trial					-2.07	-0.37	-1.29	-0.06	-0.98

Bionik Laboratories Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
EV-to-EBIT	Get a 7-Day Free Trial															-0.06	-0.56	-0.25	-1.08	-0.98

Competitive Comparison of Bionik Laboratories's EV-to-EBIT

For the Medical Care Facilities subindustry, Bionik Laboratories's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bionik Laboratories's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Bionik Laboratories's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Bionik Laboratories's EV-to-EBIT falls into.

Bionik Laboratories EV-to-EBIT Calculation

Bionik Laboratories's EV-to-EBIT for today is calculated as:

Bionik Laboratories's current Enterprise Value is $3.23 Mil.
Bionik Laboratories's EBIT for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.84 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bionik Laboratories  (OTCPK:BNKL) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Bionik Laboratories's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2023 is calculated as:

Bionik Laboratories's Enterprise Value for the quarter that ended in Mar. 2023 was $4.74 Mil.
Bionik Laboratories's EBIT for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.84 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bionik Laboratories EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Bionik Laboratories's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Bionik Laboratories (Bionik Laboratories) Business Description